Log In
Print
BCIQ
Print
Print this Print this
 

AlloStim

  Manage Alerts
Collapse Summary General Information
Company Immunovative Therapies Ltd.
DescriptionIV formulation of activated CD4+ T cells
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat refractory solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today